相关实验视频

Updated: Jul 6, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.6K

通过孟德尔的随机化和局部化分析确定了卵巢癌的潜在药物标

Sicong Liu1, Hao Lin2, Ke Zhang1

  • 1Department of Obstetrics and Gynecology, School of Medicine, Zhongda Hospital, Southeast University, Nanjing, 210003, China.

Journal of ovarian research
|February 19, 2025
PubMed
概括

这项研究使用全蛋白质门德尔随机化确定了44种与卵巢癌 (OC) 风险相关的蛋白质. 这些蛋白质,包括GRAMD1C和RBP4,显示出因果关系,并有可能成为卵巢癌的新疗法标.

关键词:
目标药物是药物目标.门德尔的随机化卵巢癌是发生在卵巢中的癌症.蛋白质蛋白质是一种蛋白质.

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.6K

相关概念视频

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...